368
Views
18
CrossRef citations to date
0
Altmetric
Pharmaceutical Analysis

Electrochemical Determination of Methamphetamine in Human Plasma on a Nanoceria Nanoparticle Decorated Reduced Graphene Oxide (rGO) Glassy Carbon Electrode (GCE)

, , &
Pages 2509-2522 | Received 30 Sep 2020, Accepted 09 Jan 2021, Published online: 01 Feb 2021
 

Abstract

Methamphetamine is an addictive and illegal psychostimulant drug. Due to its simple synthesis, it is widely accessible and abused. Long-term consumption affects the user’s body. Hence, its determination is of great importance. Its oxidation on electrode surfaces is difficult and requires a suitable modifier. In this work, cerium oxide nanoparticles (nanoceria) decorated on reduced graphene oxide were utilized as the electrode modifier to improve the electrochemical response. Decoration of nanoceria in reduced graphene oxide enhances the stability of reduced graphene oxide on the electrode surface and avoiding π-π stacking and the formation of a graphite structure. In addition, the agglomeration of nanoceria decorated on the reduced graphene oxide is decreased. The optimum ratio of cerium oxide-reduced graphene oxide composite provided a synergistic catalytic effect upon the methamphetamine signal. An enhancement of the methamphetamine oxidation peak on the modified electrode at +0.9 V in Britton-Robinson buffer was observed by cyclic voltammetry at pH 10.0 in comparison with a bare electrode. Square wave voltammetry (SWV) was used for analysis. Under the optimized conditions, the linear dynamic range and limit of detection for the reported electrode were from 25.0 to 166.6 µM and 8.7 µM. The determination of methamphetamine in plasma indicated no significant matrix interferences.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Additional information

Funding

This study was financially supported by University of Kashan and Center of Excellence in Electrochemistry, University of Tehran.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.